These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 15469788)

  • 1. [Effect of the early administration of pravastatin on C-reactive protein and interleukin-6 levels in the acute phase of myocardial infarction with ST segment elevation].
    Gonzálvez M; Ruiz Ros JA; Pérez-Paredes M; Lozano ML; Giménez DM; Martínez-Corbalán F; Carnero A; Cubero T; Gómez AE; Vicente V
    Rev Esp Cardiol; 2004 Oct; 57(10):916-23. PubMed ID: 15469788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes of plasma inflammatory markers after withdrawal of statin therapy in patients with hyperlipidemia.
    Li JJ; Li YS; Chu JM; Zhang CY; Wang Y; Huang Y; Chen J; Yuan JQ; Huang YL
    Clin Chim Acta; 2006 Apr; 366(1-2):269-73. PubMed ID: 16343471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of aspirin plus clopidogrel on inflammatory markers in patients with non-ST-segment elevation acute coronary syndrome.
    Chen YG; Xu F; Zhang Y; Ji QS; Sun Y; Lü RJ; Li RJ
    Chin Med J (Engl); 2006 Jan; 119(1):32-6. PubMed ID: 16454979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential impact of admission C-reactive protein levels on 28-day mortality risk in patients with ST-elevation versus non-ST-elevation myocardial infarction (from the Monitoring Trends and Determinants on Cardiovascular Diseases [MONICA]/Cooperative Health Research in the Region of Augsburg [KORA] Augsburg Myocardial Infarction Registry).
    Kuch B; von Scheidt W; Kling B; Heier M; Hoermann A; Meisinger C
    Am J Cardiol; 2008 Nov; 102(9):1125-30. PubMed ID: 18940277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between uncontrolled risk factors and C-reactive protein levels in patients receiving standard or intensive statin therapy for acute coronary syndromes in the PROVE IT-TIMI 22 trial.
    Ray KK; Cannon CP; Cairns R; Morrow DA; Rifai N; Kirtane AJ; McCabe CH; Skene AM; Gibson CM; Ridker PM; Braunwald E;
    J Am Coll Cardiol; 2005 Oct; 46(8):1417-24. PubMed ID: 16226164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of C-reactive protein and interleukin-6 as predictors of outcomes in patients with chronic obstructive pulmonary disease receiving pravastatin.
    Lee TM; Lin MS; Chang NC
    Am J Cardiol; 2008 Feb; 101(4):530-5. PubMed ID: 18312772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Kinetics of C-reactive protein release in different forms of acute coronary syndrome].
    Sánchez PL; Rodríguez MV; Villacorta E; Albarrán C; Cruz I; Moreiras JM; Martín F; Pabón P; Fernández-Avilés F; Martín-Luengo C
    Rev Esp Cardiol; 2006 May; 59(5):441-7. PubMed ID: 16750141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time-dependent changes of hs-CRP serum concentration in patients with non-ST elevation acute coronary syndrome.
    Jahn J; Hellmann I; Maass M; Giannitsis E; Dalhoff K; Katus HA
    Herz; 2004 Dec; 29(8):795-801. PubMed ID: 15599677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The significance of admission hs-CRP in patients undergoing primary percutaneous intervention for acute myocardial infarction].
    Cağli KE; Topaloğlu S; Aras D; Günel EN; Ozlü MF; Uygur B; Baysal E; Sen N
    Turk Kardiyol Dern Ars; 2009 Jan; 37(1):19-25. PubMed ID: 19225249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-reactive protein, interleukin-6, secretory phospholipase A2 group IIA and intercellular adhesion molecule-1 in the prediction of late outcome events after acute coronary syndromes.
    Hartford M; Wiklund O; Mattsson Hultén L; Persson A; Karlsson T; Herlitz J; Caidahl K
    J Intern Med; 2007 Nov; 262(5):526-36. PubMed ID: 17908161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Admission C-reactive protein serum levels and survival in patients with acute myocardial infarction with persistent ST elevation.
    Canale ML; Stroppa S; Caravelli P; Petronio AS; Mariotti R; Mariani M; Balbarini A; Barsotti A
    Coron Artery Dis; 2006 Dec; 17(8):693-8. PubMed ID: 17119378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma CRP level predicts left ventricular function and exercise capacity in patients with acute myocardial infarction.
    Pandian S; Amuthan V; Sukumar P; Janarthanan RA; Murugan S; Palanichamy S; Subramaniam G; Annamalai M
    Indian Heart J; 2005; 57(1):54-7. PubMed ID: 15852896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early prognostic usefulness of C-reactive protein added to the Thrombolysis In Myocardial Infarction risk score in acute coronary syndromes.
    Foussas SG; Zairis MN; Lyras AG; Patsourakos NG; Tsirimpis VG; Katsaros K; Beldekos DJ; Handanis SM; Mytas DZ; Karidis KS; Tselioti PG; Prekates AA; Ambrose JA
    Am J Cardiol; 2005 Aug; 96(4):533-7. PubMed ID: 16098307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Predictive value of the markers of inflammation in acute coronary syndromes].
    Ben Khalfallah A; Sanaa I; Annabi N; Ousji M; Aloui H; Naffeti S
    Arch Mal Coeur Vaiss; 2005 Sep; 98(9):899-905. PubMed ID: 16231577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized comparison of the effects of ASA plus clopidogrel versus ASA alone on early platelet activation in acute coronary syndromes with elevated high-sensitivity C-reactive protein and soluble CD40 ligand levels.
    Vavuranakis M; Latsios G; Aggelis D; Bosinakou I; Karambelas I; Tousoulis D; Toutouzas K; Stefanadis C
    Clin Ther; 2006 Jun; 28(6):860-71. PubMed ID: 16860169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of the usefulness of suction drainage in the treatment of nonspecific bone infections monitored with C-reactive protein].
    Milankov M; Jovanović A; Milicić A; Somer T; Vukadinović S; Savić D
    Med Pregl; 1999; 52(11-12):489-94. PubMed ID: 10748773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporal course of pregnancy-associated plasma protein-A in angioplasty-treated ST-elevation myocardial infarction patients and potential significance of concomitant heparin administration.
    Terkelsen CJ; Oxvig C; Nørgaard BL; Glerup S; Poulsen TS; Lassen JF; Møller HJ; Thuesen L; Falk E; Nielsen TT; Andersen HR
    Am J Cardiol; 2009 Jan; 103(1):29-35. PubMed ID: 19101225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRP, IL-6 and endothelin-1 levels in patients undergoing coronary artery bypass grafting. Do preoperative inflammatory parameters predict early graft occlusion and late cardiovascular events?
    Hedman A; Larsson PT; Alam M; Wallen NH; Nordlander R; Samad BA
    Int J Cardiol; 2007 Aug; 120(1):108-14. PubMed ID: 17141340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ranitidine reduces postoperative interleukin-6 induced C-reactive protein synthesis.
    Rasmussen LA; Nielsen HJ; Sørensen S; Sørensen C; Rasmussen R; Sørensen S; Moesgaard F; Larsen J
    J Am Coll Surg; 1995 Aug; 181(2):138-44. PubMed ID: 7627386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Baseline systemic inflammatory status and no-reflow phenomenon after percutaneous coronary angioplasty for acute myocardial infarction.
    Niccoli G; Lanza GA; Spaziani C; Altamura L; Romagnoli E; Leone AM; Fusco B; Trani C; Burzotta F; Mazzari MA; Mongiardo R; Biasucci LM; Rebuzzi AG; Crea F
    Int J Cardiol; 2007 May; 117(3):306-11. PubMed ID: 16859772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.